✦ LIBER ✦

Open-label, uncontrolled, clinical trial of barnidipine hydrochloride in Korean patients with renal parenchymal hypertension

✍ Scribed by Hyeong Cheon Park; Kun Ho Kwon; Hyun Jin Noh; In Hee Lee; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Ho Yung Lee; Dae Suk Han; Minoru Yamamoto

Book ID: 117090148
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 564 KB
Volume: 61
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(00)90020-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, uncontrolled, 8-week clin

An open-label, uncontrolled, 8-week clinical trial of barnidipine hydrochloride, a once-daily calcium channel blocker, in Korean patients with essential hypertension

✍ Jong-Hoa Bae; Jyo Jung Lee; Sun Hee Kwon; Heung Sun Kang; Chung Whee Choue; Kwon 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 361 KB

Antihypertensive efficacy and tolerabili

Antihypertensive efficacy and tolerability of barnidipine hydrochloride in patients with renal parenchymal hypertension

✍ Woo Sung Huh; Yun Soo Kim; Jin Suk Han; Suhng Gwon Kim; Soon Bae Kim; Jung Sik P 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 738 KB

Efficacy and tolerability of fixed, low-

Efficacy and tolerability of fixed, low-dose combination therapy with verapamil sustained-release and trandolapril in patients with mild to severe essential hypertension uncontrolled by monotherapy: an open-label, multicenter trial

✍ Kamil Adalet; Hüseyin Oflaz; Alpay Sezer; Kemalettin Büyüköztürk 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 737 KB

A 6-Month, Open-Label, Multicenter Clini

A 6-Month, Open-Label, Multicenter Clinical Study in Korean De Novo Renal Transplant Patients Evaluating the Efficacy, Safety, and Tolerance of Myfortic Concomitantly Used with Tacrolimus

✍ M.K. Ju; S.H. Park; S.J. Kim; I.S. Moon; Y.S. Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 183 KB